Belite Bio Inc (BLTE)
NASDAQ: BLTE
· Real-Time Price · USD
65.16
-1.47 (-2.21%)
At close: Aug 18, 2025, 3:59 PM
64.95
-0.32%
After-hours: Aug 18, 2025, 04:42 PM EDT
-2.21% (1D)
| Bid | 47.52 |
| Market Cap | 2.12B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -42.55M |
| EPS (ttm) | -1.55 |
| PE Ratio (ttm) | -42.04 |
| Forward PE | -43.41 |
| Analyst | Buy |
| Ask | 83.75 |
| Volume | 32,332 |
| Avg. Volume (20D) | 52,087 |
| Open | 67.31 |
| Previous Close | 66.63 |
| Day's Range | 64.60 - 67.89 |
| 52-Week Range | 43.70 - 86.53 |
| Beta | -1.50 |
About BLTE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BLTE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BLTE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+3.83%
Belite Bio shares are trading higher after the com...
Unlock content with
Pro Subscription
6 months ago
+3.58%
Belite Bio shares are trading higher after Benchmark raised its price target on the stock from $57 to $79.
